News-Medical.Net on MSN43m
ViiV Healthcare’s investigational broadly neutralising antibody - N6LS - successfully maintains viral suppression in long-acting treatment of HIV
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced positive findings from the company’s EMBRACE phase IIb study.
LiveLaw37m
Kerala HC Asks State About Testing Technology Used In Regional Cancer Centre Where Patient Contracted HIV After Blood Transfusions
The Kerala High Court asked the state government to submit an affidavit about the machines that is now being used in the ...
The Manila Times on MSN32m
US aid cuts hit Ethiopia's fragile Tigray region
As a displaced person in Ethiopia's northern Tigray region, 76-year-old Haile Tsege is no stranger to hunger. During its war ...